Eric Schmidt on its list of the 50 most important people on the Web, along with Google co-founders Page and Brin. Schmidt is one of a few people who became billionaires (in United States dollars) based on stock options received as employees in corporations of which they were neither the founders nor relatives of the founders. In its 2011 'World's Billionaires' list, "Forbes" ranked Schmidt as the 136th-richest person in the world, with an estimated wealth of $7 billion. On 20 January 2011, Google announced that Schmidt would step down as the CEO of Google but continue as the executive chairman of
MannKind Corporation in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin). Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman. In November 2015, Hakan Edstrom stepped down as CEO and president and will remain until July, 2017 to provide other services for the company. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In May 2017, Michael Castagna was named CEO of MannKind Corporation. MannKind's corporate headquarters are in Westlake